Skip to main content
Clinical Trials/CTRI/2020/01/022961
CTRI/2020/01/022961
Not Yet Recruiting
Phase 4

A Clinical Study To Evaluate The Therapeutic Effect Of Shubhdeep Swasha Hara Pill In The Management Of Tamaka Shwasa W.S.R. to Bronchial Asthma

Self0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Self
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Self

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients presenting with clinical features of Bronchial Asthma 2\)Patients aged between 16\-70 years with irrespective of gender 3\)Peak Expiratory flow Rate more than 80 Lit/min \& less than 300 Lit/min.

Exclusion Criteria

  • 1\)Patient aged less than 16 yr and more than 70 yrs 2\)Peak Expiratory flow Rate less than 80 Lit/min are excluded 3\)Asthma in pregnancy 4\)Patients with severe attacks of Bronchial Asthma 5\)Patients of Bronchial Asthma also suffering from other systemic disorders 6\)The Bronchial asthma, associated with complications like emphysema and cor pulmonale. •

Outcomes

Primary Outcomes

Not specified

Similar Trials